Prelude Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Prelude Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-132,619	Closed	-$5.59M	–	1457
2023 Q2	$5.59M	Buy	+132,619	New	+$5.36M	0.36%	41
2022 Q2	–	Sell	-2,474	Closed	-$200K	–	2176
2022 Q1	$200K	Sell	2,474 -7	-0.3%	-$592	0.01%	1270
2021 Q4	$255K	Sell	2,481 -7,535	-75%	-$724K	0.01%	1414
2021 Q3	$876K	Sell	10,016 -4,399	-31%	-$398K	0.02%	620
2021 Q2	$1.29M	Sell	14,415 -4,187	-23%	-$354K	0.04%	477
2021 Q1	$1.41M	Buy	18,602 +5,832	+46%	+$440K	0.04%	468
2020 Q4	$870K	Buy	12,770 +1,822	+17%	+$114K	0.02%	519
2020 Q3	$582K	Buy	10,948 +9,718	+790%	+$579K	0.03%	404
2020 Q2	$72K	Buy	+1,230	New	+$66.1K	﹤0.01%	1048
2019 Q2	–	Sell	-526	Closed	-$27K	–	2252
2019 Q1	$27K	Buy	526 +62	+13%	+$3.01K	﹤0.01%	1265
2018 Q4	$18K	Buy	+464	New	+$21.6K	﹤0.01%	1265
2017 Q1	–	Sell	-1,200	Closed	-$63K	–	1851
2016 Q4	$63K	Buy	1,200 +200	+20%	+$9.68K	0.01%	981
2016 Q3	$45K	Sell	1,000 -1,100	-52%	-$47.7K	﹤0.01%	1074
2016 Q2	$80K	Sell	2,100 -5,030	-71%	-$221K	0.01%	838
2016 Q1	$294K	Buy	7,130 +2,499	+54%	+$103K	0.04%	412
2015 Q4	$225K	Buy	+4,631	New	+$206K	0.03%	510
2015 Q3	–	Sell	-1,569	Closed	-$63K	–	1873
2015 Q2	$63K	Sell	1,569 -28	-2%	-$966	0.01%	1070
2015 Q1	$52K	Buy	+1,597	New	+$44.1K	0.01%	1264

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's SYNH Position: Q3 2023 in Review

Prelude Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 132,619 shares — an estimated $5.59M sold.

Prelude Capital Management first reported a position in SYNH in Q1 2015 and held it in 18 quarters. The position peaked at $5.59M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Prelude Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Prelude Capital Management sold 132,619 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $5.59M.
Prelude Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 18 quarters.
Prelude Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $5.59M in Q2 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.